INHIBITION OF THE LEUKEMOGENICITY OF MYELOID LEUKEMIC CELLS IN MICE AND IN VIVO INDUCTION OF NORMAL DIFFERENTIATION OF THE

Similar documents
[GANN, 62, ; April, 1971]

Sensitized Mice. cells (Japan strain, Japan BCG Co., Tokyo) were. grown in Dubos broth medium (Difco Laboratories,

Interferon Immunosuppression: Mediation by a Suppressor

Cultural Characteristics of a Cell Line Derived

Interferon-Producing Capacity of Germfree Mice

Immune enhancement by increased number of B-cells

ELECTRON-MICROSCOPIC OBSERVATIONS OF POLYOMA VIRUS-TRANSFORMED MOUSE CELLS TREATED WITH SPECIFIC IMMUNE SERUM

Agent. line of mouse L-cell fibroblasts (L929), originally obtained from the American Type Culture Collection Cell Repository.

Transfer Agent of Immunity. VI. Serial Passive Transfers of Cellular Immunity to Salmonella Infection by Immune Ribonucleic Acid

Nature Biotechnology: doi: /nbt.4086

Convoy TM Transfection Reagent

IMMUNIZATION AGAINST EHRLICH MOUSE ASCITES CARCINOMA WITH CHEMICALLY DEVITALIZED TUMOR CELLS *

PARTIALLY PURIFIED LENTINAN FROM SHIITAKE MUSHROOM (LENTINUS EDODES) STILL RETAIN ANTITUMOUR ACTIVITY

The flow diagram below shows part of a process to produce a protein, using genetically modified plants.

antigen." 2 Moreover, when mixed populations of normal and sensitive cells

ICH CONSIDERATIONS Oncolytic Viruses

Supplementary Methods Antibodies for flow cytometry Cytotoxicity assay

Chapter 14. Second symmetry

UNIVERSITY OF TEXAS AT ARLINGTON INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE MONOCLONAL ANTIBODIES/MOUSE ASCITES SOP

obtained from the infected and treated tissues, Fleming's2 technic of hemolytic streptococcus B. Immediately following the infection, 1.0 ml.

Tumor-Associated Transplantation Antigens in Immune Rejection of Mouse Malignant Cell Hybrids

ICH Considerations. Oncolytic Viruses September 17, 2009

A Sex-Limited Serum Protein Variant in the Mouse: Hormonal Control of Phenotypic Expression

Autocrine Complement Inhibits IL10-Dependent T-Cell Mediated. Antitumor Immunity to Promote Tumor Progression

01/08/2018. Control of Microbial Growth. Methods. Terminology. Disinfectants and Antiseptics. Three approaches. Cleaning. Chemical.

Development of NOG mice

THE EFFECT OF ANTISERUM FRACTIONS ON EHRLICH ASCITES TUMOUR CELLS

EFFECT OF THE SIZE OF INOCULUM ON THE GROWTH OF TRANSPLANTABLE RAT TUMORS 1

A New Killer Factor Produced by a Killer/Sensitive Yeast Strain

Cells Culture Techniques Marta Czernik

Screening of Anticancer Materials from Myxobacteria and Evaluation of Their Bioactivity in Vivo

Grouping of Feline Calicivirus Field Isolates Using Monoclonal Antibodies

Supplementary figures

Stem Cel s Key Words:

Xeno-Free Systems for hesc & hipsc. Facilitating the shift from Stem Cell Research to Clinical Applications

Solutions for Your Research

Data Sheet CD137/NF-κB Reporter - HEK293 Recombinant Cell Line Catalog # 79289

Specific Immune Response Against Tumor-Associated of a Syngeneic Simian Virus 40-lnduced Sarcoma in

Gene Technology classification of dealings involving self-inactivating, replication defective, retroviral vectors.

North American Ginseng & Auricularia sp. mushroom aq. extract have beneficial effect on cyclophosphamide induced immunosuppression in mice

For in vitro killing assays with lysed cells, neutrophils were sonicated using a 550 Sonic

PASSIVE PROTECTION BY HUMAN SERUM IN MICE INFECTED WITH ENCAPSULATED STAPHYLOCOCCUS A UREUS

TITLE: A Fusogenic Oncolytic Herpes Simplex Virus for Therapy of Advanced Ovarian Cancer

Investigations in Immune Suppression for Monoclonal Antibody Therapeutics

Dextran Sulphate 500 Delays and Prevents Mouse Scrapie by Impairment of Agent Replication in Spleen

Human IFN-γ. Pre-Coated ELISA Kit

Alternatives to In-Vivo Testing for Animal Biologics: North American Regulatory Perspective

Experimental models for lead optimisation of novel antileishmanial agents Sunil Puri, PhD

Mid-term review. Recitation5 03/31/2014. Stem Cell Biology and Function W4193 1

RXi Pharmaceuticals. BioPharm America September 26, 2017 NASDAQ: RXII. Property of RXi Pharmaceuticals

Gene Technology classification of dealings involving self-inactivating, replication defective, retroviral vectors.

York University School of Medicine, NY. Bhagavathi A. Narayanan, PhD 1, Caroline Cunnigham 1 and Amitabha Mazumder, MD 2. Title

Retinoic acid (vitamin A acid) induced transcriptional control

Replication of Vesicular Stomatitis Virus Facilitated by Shope

Developing Targeted Stem Cell Therapeutics for Cancer. Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013

ICH Considerations Oncolytic Viruses ONCOLYTIC VIRUSES (EMEA/CHMP/ICH/607698/2008) TRANSMISSION TO CHMP November 2008

Gene therapy has gained significant attention over the past two decades as a potential method for treating genetic disorders such as severe combined

SUPPLEMENTARY INFORMATION

Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology

1. Immunization. What is Immunization? 12/9/2016. Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology

Recombinant, Insect Cell-Derived RSV Nanoparticle Vaccine

Human GM-CSF ELISA Kit

Rabbit Anti-Mouse/Rat Asialo GM1 Polyclonal Antibody

MCB 4211, Fall 2018, Practice Exam 1 Last, First name Student ID # Seat No. ***NOTE: Exam will have 40 multiple choice questions.

a. Hypoxanthine was present in the media. MCB 4211, Fall 2018, Practice Exam 1 Last, First name Student ID # Seat No.

Outline. o Immunogenicity of therapeutic protein aggregates. o Clinical evidence. o Models to study the immunogenicity of aggregates

Supplemental Information Inventory

Data Sheet HVEM/NF-κB Reporter Jurkat Recombinant Cell Line Catalog # 79310

Tumor-infiltrating dendritic cells suppress nucleic acid-mediated. innate immune responses through TIM-3-HMGB1 interactions

Rabies Potency Testing

Antibodies to Animal Cells and Serum Proteins

Mouse Strain Resistant to N-, B-, and NB-Tropic Murine Leukemia Viruses

Purification of Host DNA Synthesis-Suppressing Factor (DSF) Produced by Infection with Measles Virus

The RT-qPCR analysis of selected type-i IFNs related genes, IRF7 and Oas3. The

Linker p. 177 Helper Lipid p. 178 Delivery to Target Cells p. 180 Cell Entry p. 182 Receptor-Mediated Uptake p. 182 Endosomai Release p.

Supplemental methods:

Activation of Mouse Peritoneal Cells to Kill Listeria

Modulation of Immune Response in Lambs

c) Assuming he does not run another endurance race, will the steady-state populations be affected one year later? If so, explain how.

AN EXAMINATION OF THE EFFECTS OF SIMVASTATIN ON INNATE IMMUNE RESPONSES TO S. AUREUS A RESEARCH PAPER BY TRACI STANKIEWICZ

Protocol for induction of expression and cell lysate production

Examination in Immunotechnology, 30 May 2011, 8-13

Supplemental Information

Nanogel-Based Immunologically Stealth Vaccine Targets Macrophages in the Medulla of Lymph Node and Induces Potent Antitumor Immunity

Data Sheet. Glucocorticoid Receptor Pathway GAL4 Reporter (Luc)-HEK293 cell Line Catalog #: w70666

Purification of a Novel Growth Inhibitory Factor for Partially Differentiated Myeloid Leukemic Cells*

Data Sheet. MAPK/ERK Signaling Pathway SRE Reporter HEK293 Cell Line Catalog #: 60406

Apoptosis And Anti-tumor Effect Induced By Mtor Inhibitor And Autophagy Inhibitor In Human Osteosarcoma Cells

CHAPTER 7 CELLULAR BASIS OF ANTIBODY DIVERSITY: CLONAL SELECTION

Page 1 of 5. Product Name Label Quantity Product No. Cy 3 10 µg (~0.75 nmol) MIR Cy µg (~7.5 nmol) MIR 7901

Data Sheet. Glucocorticoid Receptor Pathway GR-GAL4 Reporter (Luc)-HEK293 cell Line Catalog #: 60655

Midori Green Advance DNA Stain Safety Report

Inhibition of Herpesvirus hominis Replication by Human Interferon

those obtained from tissues or intact animals. spleen tissue cultures were exposed to LPS at 230C, an early product produced after 24 h of

DepoVax TM : A novel delivery formulation for cancer immunotherapy and infectious disease vaccines

Implications of TL Phenotype Changes in an H-2-Loss Variant of a Transplanted H-2b/H-2a Leukemia*

Immunogenicity of Therapeutic Proteins. Steven J Swanson, Ph.D. Executive Director, Clinical Immunology

Required Materials. Stemgent Reprogramming-Qualified Nuff Cells GSC-3006G 4 x 10 6 cells/vial Liquid Nitrogen

TUMOUR-NECROSIS FACTOR FROM THE RABBIT. V. SYNTHESIS

Transcription:

INHIBITION OF THE LEUKEMOGENICITY OF MYELOID LEUKEMIC CELLS IN MICE AND IN VIVO INDUCTION OF NORMAL DIFFERENTIATION OF THE Mikio TOMIDA, Yuri YAMAMOTO, and Motoo HOZUMI Department of Chemotherapy, Saitama Cancer Center Research Institute* The effects of synthetic RNAs on the leukemogenicity of mouse myeloid leukemic M1 cells were studied in syngeneic SL mice. M1 cells are known to be capable of differentiating into macrophages and granulocytes both in vitro and in vivo. Mice that had been inoculated with three different clones (T-22, R-4 and DR-3) of M1 cells varying in sensitivity to inducers of differentiation died 20 to 40 days after inoculation. However, 10 out of 14 mice inoculated with the slightly prolonged the survival times of mice inoculated with some clones of M1 cells. lating activity, which induced differentiation of M1 cells in vitro, were markedly induced within 3hr in the serum of the mice. cells was examined by implanting diffusion chambers containing the cells into syngeneic SL strain mice. The in vivo inductions of differentiation of three clones (T-22, R-4 and DR-3) of M1 cells in untreated mice varied, but all three clonal cells showed marked differentiation into macrophages and granulocytes in mice These results suggest that stimulation of induction of normal differentiation and interferon to the leukemic cells and immunopotentiating activity of the RNA may also be involved. differentiation-leukemogenicity Mouse myeloid leukmic M1 cells can be induced to differentiate into macrophages and granulocytes both in vitro15,16) and in vivo,8,20,25) and various inducers of in vitro differentiation of M1 cells are known.13,27) A protein inducer(s), designated as D-factor (differentiation-stimulating factor)11,12,22) or MGI (macrophage and granulocyte inducer),27) was found in conditioned media of various cultured cells,14,15,22,29) ascitic serum.4) Macrophages and granuloctyes were suggested to be mainly responsible for the production of D-factor.11,12,15) We previously showed that double-stranded RNAs

duction of D-factor by mouse peritoneal macrophages in vitro.29) Furthermore, we found that these RNAs directly affect M1 cells, making them more sensitive to D- factor.32) These RNAs did not themselves induce differentiation of M1 cells, but they markedly stimulated the induction by a low concentration of D-factor. The effect of these RNAs was concluded to be mediated by induced interferon,32) because the RNAs also induced interferon in M1 cells, because partially purified interferon had a stimulatory effect on the differentiation of M1 cells and because the stimulatory effect of the RNAs was abolished by simultaneous treatment of the M1 cells with anti-interferon serum. On the other hand, it was shown that differentiated M1 cells induced in vitro could no longer develop into tumors in syngeneic SL strain mice.5,16) Honma et al.8) also reported a correlation between leukemogenicity and in vivo inducibility of differentiation in several clones of M1 cells. Therefore, we tried to inhibit the development of M1 cell leukemia in syngeneic SL mice by enhancing the induction of normal differentiation of the cells with synthetic RNAs. MATERIALS AND METHODS Animals About 60-day-old, specific pathogenfree SL strain mice maintained in this laboratory were used throughout. Cells Myeloid leukemic M1 cells were originally obtained from a spontaneous myeloid leukemia in an SL strain mouse.15) Clone T-22 cells29) can be induced to differentiate into macrophages and granulocytes by inducers such as D-factor or glucocorticoid hormones. Clone R-424) and DR- 37) cells, which cannot be induced to differentiate in vitro by inducers alone, were also isolated from M1 cells. The cells were cultured in Eagle's minimal essential medium (Nissui Seiyaku Co., Tokyo), supplemented with double the usual concentrations of amino acids and vitamins and M. TOMIDA, ET AL. Culture of Cells in Diffusion Chambers The chambers were made from Millipore mem- scribed previously,2,8) and 0.1ml of cell suspension into each one. Two chambers were implanted into the peritoneal cavity of each mouse that had received no pretreatment. The cells were collected after 4 days by processing the chambers in 0.5% pronase and 5% Ficoll-400 in Hanks' balanced with May-Grunwald-Giemsa stain. More than 200 cells from each chamber were analyzed for the determination of morphological differentiation. Assay of Interferon Interferon in mouse serum was assayed by determining the inhibition of 3H-uridine incorporation into vesicular stomatitis virus RNA in L cells by the method of Kawade et al.17) In this work titers of interferon were measured with NIH reference standard mouse interferon (Cat. No., G002-904-511) as a standard and are expressed in international reference units (IU). Assay of D-factor Activity of D-factor in mouse serum was assayed by measuring the induction of phagocytic activity in M1 cells by the serum. M1 (T-22) cells were incubated with various concentrations of the serum for 2 days and then their phagocytic activity was assayed as described previously,29) using polystyrene latex poly(u) and poly(i) were obtained from Yamasa Shoyu, Choshi. RESULTS Effects of Treatment with Synthetic RNAs on the Survival of Mice Inoculated with Various Clones of M1 Cells We inoculated ip 105 cells of three different clones of M1 cells into SL mice. As shown in Fig. 1, all the mice inoculated with T-22 clonal cells, which could be induced to differentiate in vitro by inducers such as D- factor and glucocorticoid, died 29 to 40 days after inoculation. Mean survival times of mice inoculated with R-4 and DR-3 clonal cells, which were less sensitive to inducers, tively. The difference in leukemogenicity between sensitive T-22 cells and resistant R-4 and DR- 3 cells is significant (P<0.001). Honma et al.8) previously showed a clear difference in Gann

Fig, 1. Effects of synthetic RNAs on the survival EFFECT OF POLY I:C ON MYELOID LEUKEMIA times of mice inoculated with M1 cells Clone T-22 (a), R-4 (b) or DR-3 (c) cells at 105 cells per 0.2ml of phosphate-buffered saline were inoculated ip into SL mice. Synthetic RNAs in 0.2ml of phosphatebuffered saline were injected ip at the time of cell inoculation and then twice a week until day 93. Groups of leukemogenicity between the resistant and the sensitive cells with a smaller inoculum size (104 cells/mouse). poly(u) and poly(i) were injected ip at the time of cell inoculation and then twice weekly at doses that were not toxic to the mice. Survival of mice inoculated with each clone of M1 cells was markedly prolonged out of 5 mice inoculated with T-22 cells, 3 out of 5 mice inoculated with R-4 cells and 3 out of 4 mice inoculated with DR-3 cells survived for more than 100 days. Three and one of the survivors inoculated with DR-3 cells and R-4 cells, respectively, died of leu- (125 days from the first treatment) with killed at day 165. mouse) for the suppression of leukemia. A similar difference in the effectiveness of the leukemic cells was observed in vitro: a 50- to 100-fold higher concentration of poly quired for the induction of interferon and stimulation of differentiation of T-22 cells.32) We previously showed that T-22 clone cells, but not R-4 or DR-3 clone cells, were induced to differentiate in vitro by treatment days.30) Therefore, we expected an inhibitory effect of poly(i) on the leukemogenicity of the sensitive T-22 cells. The mean survival time of mice injected with T-22 cells Induction of Interferon and Differentiation-stimulating Activity in Mouse feron. We have found that interferon stimulated the induction of differentiation of M1 cells by D-factor (Cancer Res., in press), poly(c) enhanced the production of D- factor in mouse peritoneal macrophages in vitro.29) Hence, we examined the effect of feron and D-factor in vivo. As shown in Fig. 2, the activities of interferon and D-factor were not detectable in the serum of untreated mice (0 time), but both activities were induced within 3hr af- gradually decreased. Interferon disappeared

M. TOMIDA, ET AL. induction of differentiation of M1 cells M1 cells were cultured in diffusion chambers in SL of the diffusion chambers. Fig. 2. Activities of interferon and D-factor in Serum was collected from 3 mice at the indicated times and pooled. Activities of interferon and D-factor in the sera were assayed as described in "Materials and Methods." Activity of D-factor was assayed with 1% more rapidly than the differentiation-stimulating activity. Significant activity of D- factor remained for 72hr after treatment Induction of Differentiation of M1 Cells In vivo induction of differentiation of cells was demonstrated by the diffusion chamber technique.8,20,25) In untreated mice, the induction of differentiation of M1 cells was correlated with the in vitro sensitivity of the cells to inducers such as D-factor and dexamethasone. As shown in Fig. 3, T-22 cells, but not R-4 or DR-3 cells, were induced to differentiate into mature macrophages and granulocytes within 4 days after their implan- poly(c) into the mice, even resistant R-4 and DR-3 cells were induced to differentiate (Fig. 4), and differentiation of the sensitive T-22 cells was significantly stimulated. DISCUSSION We clearly demonstrated that injection times of mice inoculated with myeloid leukemic M1 cells and stimulated in vivo induction of differentiation of the cells. The mechanisms of inhibition of leukemogenicity known, but stimulation of the normal differentiation of the leukemic cells seems to be Gann

EFFECT OF POLY I:C ON MYELOID LEUKEMIA

one of the mechanisms, since it was shown that, on differentiation in vitro, M1 cells lose both proliferating activity and leukemogenicity,5,16) and that the leukemogenicity of each clone of M1 cells is inversely correlated with its in vivo inducibility of differentiation.8) Furthermore, leukemogenicity of M1 cells was recently shown9) to be inhibited by the injection into mice of inducers (lipopolysaccharide31) and dexamethasone) of differentiation of the cells. In the present paper, we showed that M. TOMIDA, ET AL. suited in the induction of D-factor activity and interferon in their sera. Lotem and Sachs21) and we found that an appropriate concentration of interferon stimulated the induction of differentiation of M1 cells by a low concentration of D-factor in vitro (Cancer Res., in press). Therefore, stimulation of in vivo induction of differentiation of M1 cells Lion of D-factor and interferon by the RNA. Although we observed stimulation by activity of macrophages1,28) and natural killer cells.3) Therefore, these various actions ferentiation of M1 cells, including clones which were resistant to inducers in vitro, no definitive correlation was observed between the differentiation of the cells and the survival times of the leukemic mice (Figs. 1 and 3). T-22 cells could differentiate into macrophages and granulocytes in untreated mice to almost the same degree that DR-3 cells most resistant to treatment with the RNA mice. However, mice injected with DR-3 examine myeloid leukemia. To our knowl- better than those that received T-22 cells alone. Therefore, stimulation of the induction poly(c) is not the only mechanism of inhibition of leukemogenicity of the cells by the RNA. One possible mechanism involved may be kemic cells. Treatment of T-22 cells with 5 ug/ml of the RNA in vitro for 2 days reduced DR-3 cells could tolerate even 1mg/ml of the RNA (85 and 95% of the growth of controls, respectively). Therefore, a direct cytotoxic effect of the RNA on T-22 cells may contribute to the prolongation of the survival times of mice inoculated with these cells. Although a difference in the antigenicity of each clone of the M1 cells against syngeneic SL mouse may also affect the leukemogenicity of the cells through immune mechanisms, no such difference in antigenicity was detected among the clones.9) Another possible mechanism of inhibition of the leukemogenicity of the leukemic cells is suppression of growth of the cells by interferon induced by the RNA. Suppression by interferon of in vitro growth of M1 cells was recently observed. Unexpectedly, the resistant clones, R-4 and DR-3, were more sensitive to interferon than the sensitive clones, T-22. recently reported to stimulate the tumoricidal of interferon may also be involved in the (C) of the leukemogenicity of M1 cells. On the other hand, antitumor effects of various tumors. Although Levy et al.19) reported that lymphatic leukemias were the among various tumors of mice, they did not poly(c) markedly inhibits myeloid leukemia. clinically useful26) because of its rapid hydrolysis by nuclease in primate serum.23) Recently, a stabilized material consisting of poly(c) complex may be useful for the therapy of some patients with myeloid leukemia. Gann

EFFECT OF POLY I:C ON MYELOID LEUKEMIA This work was supported in part by Grantsin-Aid for Cancer Research from the Ministry of Health and Welfare, and from the Ministry of Education, Science and Culture. (Received January 23, 1980) 14) Hozumi, M., Umezawa, T., Takenaga, K., Ohno, T., Shikita, M., Yamane, I., Cancer 17) Kawade, Y., Matsuzawa, T., Yamamoto, Y., Tsukui, K., Iwakura, Y., Annu. Rep. 18) Levy, H. B., Baer, G., Baron, S., Buckler, C. E., Gibbs, C. J., Iadarola, M. J., London, 10) Hozumi, M., Sugiyama, K., Mura, M., Takizawa, H., Sugimura, T., Matsushima, T., Ichikawa, Y., Proc. 4th Int. Symp. Princess 12) Hozumi, M., Honma, Y., Okabe, J., Tomida, M., Kasukabe, T., Takenaga, K., Sugiyama, K., "Oncogenic Viruses and Host Cell Genes," ed. Y. Ikawa and T. 13) Hozumi, M., Honma, Y., Tomida, M., Okabe, J., Kasukabe, T., Sugiyama, K., Hayashi, M., Takenaga, K., Yamamoto,